Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North and South America, Europe and Asia Pacific.

Recent Press Releases

July 25, 2014 - 7:24 a.m.
European CHMP Adopts Positive Opinion for Gilead’s Zydelig® (idelalisib) for the Treatment of Chronic Lymphocytic Leukemia and Follicular LymphomaPrinter Friendly Version 

Upcoming Events

There are currently no events scheduled.

Most Viewed Links

Updated 07/31/14
1.Earnings
2.Q2 2014 Gilead Sciences Earnings Conference Call
3.Gilead Sciences Announces Second Quarter 2014 Financial Results
4.Stock Information
5.SEC Filings
* Data collected 07/23/14 - 07/30/14

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
$93.79
 Stock is Up 0.80 (0.86%)
Data as of 07/30/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Webcast Replay